Yahoo Search Búsqueda en la Web

Resultado de búsqueda

  1. 22 de sept. de 2008 · Using the Novalis Tx platform from Varian Medical Systems (NYSE: VAR) and BrainLAB, doctors are performing image-guided radiosurgery to treat tumors of the brain, spine, lung, and liver, without a single incision in the patient.

  2. Novalis Tx will offer treatment options for an extremely wide range of indications such as malignant and benign lesions, brain metastases, arteriovascular malformations, and functional lesions. It features very high dose delivery rates, which means that treatments can be delivered very rapidly.

  3. The Novalis Tx offers the most comprehensive image guidance system available, including Varian's machine-mounted 3D CT scanner with 2D radiographic and fluoroscopic imaging capability as well as BrainLab's room-mounted X-Ray imaging system for real-time imaging and motion management.

  4. The UCLA Radiosurgery and SBRT Program Has One of the Most Advanced Facilities in the World. Novalis Tx Technology. Novalis Tx is the newest advance in Stereotactic Radiosurgery (SRS) and Stereotactic Body Radiation Therapy (SBRT).

  5. Brainlab Novalis SRS Registry* is a service that supports all clinical specialties involved in radiosurgical diagnoses and treatments with tools for reporting, intelligently structuring and visualizing clinical data from different sources to advance patient-specific treatment decisions.

    • novalis tx website1
    • novalis tx website2
    • novalis tx website3
    • novalis tx website4
    • novalis tx website5
  6. What is Brainlab Novalis Circle? Brainlab Novalis Circle is a global network that connects healthcare professionals dedicated to the advancement of radiosurgery and enables them to exchange insights and collaborate, develop new ideas and continuously shape cancer treatment of the future.

  7. 10 de may. de 2012 · We have demonstrated the Novalis Tx to be a robust system, with the image guidance and MLC requirements to treat a wide variety of sites, in addition to achieving the requirements for highly accurate delivery of SRS and SBRT‐based treatments.